Elson S. Floyd College of Medicine, Washington State University, Spokane, WA, USA.
Department and Institute of Psychiatry, Programa Terceira Idade (PROTER, Old Age Research Group), University of São Paulo School of Medicine, São Paulo, Brazil.
J Alzheimers Dis. 2023;91(4):1395-1407. doi: 10.3233/JAD-220825.
American Indians have high prevalence of risk factors for Alzheimer's disease and related dementias (ADRD) compared to the general population, yet dementia onset and frequency in this population are understudied. Intraindividual cognitive variability (IICV), a measure of variability in neuropsychological test performance within a person at a single timepoint, may be a novel, noninvasive biomarker of neurodegeneration and early dementia.
To characterize the cross-sectional associations between IICV and hippocampal, total brain volume, and white matter disease measured by magnetic resonance imaging (MRI) among older American Indians.
IICV measures for memory, executive function, and processing speed, and multidomain cognition were calculated for 746 American Indians (aged 64-95) who underwent MRI. Regression models were used to examine the associations of IICV score with hippocampal volume, total brain volume, and graded white matter disease, adjusting for age, sex, education, body mass index, intracranial volume, diabetes, stroke, hypertension, hypercholesterolemia, alcohol use, and smoking.
Higher memory IICV measure was associated with lower hippocampal volume (Beta = -0.076; 95% CI -0.499, -0.023; p = 0.031). After adjustment for Bonferroni or IICV mean scores in the same tests, the associations were no longer significant. No IICV measures were associated with white matter disease or total brain volume.
These findings suggest that the IICV measures used in this research cannot be robustly associated with cross-sectional neuroimaging features; nonetheless, the results encourage future studies investigating the associations between IICV and other brain regions, as well as its utility in the prediction of neurodegeneration and dementia in American Indians.
与一般人群相比,美洲原住民患阿尔茨海默病及相关痴呆症(ADRD)的风险因素患病率较高,但该人群的痴呆症发病和发病频率研究较少。个体内认知变异性(IICV)是衡量一个人在单一时间点神经心理测试表现变异性的一种新的非侵入性神经退行性变和早期痴呆症生物标志物。
描述磁共振成像(MRI)测量的美洲印第安老年人的 IICV 与海马体、全脑体积和白质疾病之间的横断面关联。
对 746 名接受 MRI 检查的美洲印第安人(年龄 64-95 岁)的记忆、执行功能和处理速度的 IICV 测量值和多领域认知进行了计算。回归模型用于检查 IICV 评分与海马体体积、全脑体积和分级白质疾病之间的关联,调整了年龄、性别、教育程度、体重指数、颅内体积、糖尿病、中风、高血压、高胆固醇血症、酒精使用和吸烟。
较高的记忆 IICV 指标与较低的海马体体积呈负相关(Beta =-0.076;95%CI-0.499,-0.023;p =0.031)。在调整相同测试中的 Bonferroni 或 IICV 平均得分后,关联不再显著。没有 IICV 指标与白质疾病或全脑体积相关。
这些发现表明,本研究中使用的 IICV 指标不能与横断面神经影像学特征可靠相关;尽管如此,结果仍鼓励未来研究调查 IICV 与其他大脑区域之间的关联,以及其在预测美洲印第安人神经退行性变和痴呆症中的效用。